We're developing drugs for safe cellular rejuvenation and treatment of age-linked diseases by the application of machine-learning 'driver' clocks to cell reprogramming. We're on the cusp of validating drug targets and uniquely positioned to do so. To learn more contact us or watch our Foresight-series video (below)